Draft versioned claims from your manuscript with linked experiments, exact results, limitations, falsifiability notes, and provenance for reviewers.Know what the science actually supports before you trust the answer.
Press Enter β΅ to import
Explore by Goal
"The nitrogen in our DNA, the calcium in our teeth, the iron in our blood, the carbon in our apple pies were made in the interiors of collapsing stars. We are made of starstuff."
- Carl Sagan
Low confidence. Please provide more context.
Low answer quality. Please provide more context.
Quick Explanation
Copied
BGPT skeptical note: The provided βAuthor Review: Yiming Xuβ metadata does not contain enough biological/biomedical content (nor any DOIs for the listed works) to rigorously assess scientific strength in the way you requested. A robust evaluation would require the actual papersβ full texts/DOIs (or at least titles + DOIs) and evidence about methods, data quality, and reproducibility.
Epistemic humility: I can only evaluate what you provided. Your dataset mixes (i) bibliometric-like metadata for βYiming Xuβ and (ii) a separate set of full research summaries about other papers; there is no explicit mapping showing that Yiming Xu is the author of those biomedical/ML papers. Therefore, I cannot responsibly attribute those paper results to Yiming Xu.
1) What I can and cannot verify from your inputs
Can evaluate (weakly): Your provided bibliometric snapshot for βYiming Xuβ (h-index, total citations, paper count, and a list of titles/fields).
Cannot evaluate (strongly): biological scientific rigor (methods/data quality) because the listed βpapersβ contain no DOIs/full texts in the provided data, and the biomedical/biotech-focused βresearch data to utilizeβ items appear unlinked to this author.
Big red flag: The authorβs listed works (e.g., TSN scheduling, cislunar networks, camera calibration thesis, iron pnictides ARPES, electrohydraulic controller) look predominantly non-biological. That means any βscience strengthβ score for biological work would be guesswork unless we have the relevant papers.
2) Bibliometrics (from your provided snapshot)
Reported: h-index = 2, total citations = 131, paper count = 15 (plus a separate OpenAlex-like query payload that appears to match a different βYiming Xuβ or is ambiguousβsee limitations below).
Skeptical interpretation: h-index=2 typically indicates either (a) an early career stage, (b) field/citation skew (e.g., niche engineering venues), (c) author identity disambiguation issues, or (d) incomplete indexing.
3) Breadth vs. depth: field distribution in the provided title list
From the titles you included, the work spans multiple engineering/science areas rather than a concentrated biomedical specialization (e.g., networking, cislunar links, solubility/bioavailability of lutein, information bottleneck principle, control systems, rolling contact materials, camera calibration thesis, ARPES on iron pnictides, etc.).
Important limitation: This is not a statement about the authorβs actual research focusβonly about what your provided titles suggest.
4) What your βresearch data to utilizeβ contains (but why it may not be about this author)
You supplied multiple biomedical/biotech/ML paper summaries (e.g., LEADS foundation model for medical literature mining; Kawasaki IVIG-resistance risk-of-bias review; scEvolver continual learning for single-cell annotation; ST-LLM for spatial transcriptomics; integrin Ξ±5Ξ²1 targeted theranostic probes in glioblastoma; etc.).
However, none of those entries explicitly name βYiming Xuβ as an author within the provided text you shared.
Therefore, I cannot fairly credit those results to Yiming Xu.
Consequence: Any attempt to score Yiming Xuβs biological/AI/biochem rigor using these items would be a category error without author-to-paper linkage.
5) Scientific-strength assessment (given the missing evidence)
What I can infer (weakly)
The provided bibliometrics (h-index=2; 131 citations across 15 works) suggest limited citation reach so far, but this is not proof of low scientific quality (citation depends on field, visibility, time, coauthorship, and indexing).
The listed titles suggest cross-domain breadth. Cross-domain work can be valuable, but it can also indicate less depth or fewer long citation chains in a single niche.
What I cannot conclude (and why)
I cannot evaluate biological rigor (experimental design, controls, reproducibility, statistical practices) because the key papersβ metadata/full texts/DOIs were not provided for βYiming Xuβ.
I cannot evaluate computational rigor (benchmarking validity, leakage checks, ablation soundness, hyperparameter sensitivity) for Yiming Xu in the bioinformatics/AI domain without knowing which of the listed works are theirs and having the technical details.
Bottom line: The scientific-strength score must be conservative due to missing verifiable mapping between Yiming Xu and the biomedical paper summaries.
6) Concrete next step to make this review actually βBGPT-gradeβ
Provide either:
DOIs (or URLs) for the works in your Yiming Xu title list, OR
Upload the PDFs / links for those papers, OR
Confirm that the biomedical summaries block is truly authored by Yiming Xu and list which papers match.
Then BGPT can do a proper: methods check, risk-of-bias style assessment, reproducibility signals, and quantitative comparisons.
Feedback:
Updated: April 22, 2026
BGPT Author Review
Scientific Quality
20%
Very low score due to insufficient verifiable evidence: the provided material does not reliably link Yiming Xu to the biomedical/biotech paper summaries, and the listed works lack DOIs/full-text details. Without methods, controls, data, and reproducibility signals, scientific quality cannot be assessed beyond weak bibliometric hints.
Communication Quality
40%
Cannot evaluate communication quality from content; only metadata and a title list were provided. If Yiming Xuβs actual abstracts/full papers are supplied, clarity can be assessed via methods transparency, figure legibility, and statistical reporting.
Author Novelty
30%
Novelty cannot be assessed without knowing which specific contributions are biologically relevant and without access to the actual works. Title-level breadth suggests some novelty may exist, but that is not evidence.
Scientific Rigor
20%
Rigor cannot be determined without experimental/computational details (sample sizes, controls, validation, leakage checks, robustness tests). Bibliometrics alone are not a rigor metric.
Not applicable: the provided task is an author-science-strength audit without raw, author-linked bioinformatics datasets to analyze.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
βLow h-index proves low scientific rigor.β This is a strongman claim because citation metrics are field- and time-dependent and do not substitute for methods/data auditing.
βBecause the titles are diverse, the author must be shallow.β Diversity can reflect interdisciplinary skill; without paper-level evidence this is not testable.
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Analysis 
Hypothesis Graveyard
Discussion